D. Pastrello

Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity.

A. Luini, A. Goldhirsch, G. Viale, 2012, Clinical breast cancer.

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes.

A. Luini, A. Goldhirsch, G. Pruneri, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clustering of endocytic organelles in parental and drug-resistant myeloid leukaemia cell lines lacking centrosomally organised microtubule arrays.

A. Jones, Jing Jin, Neal A Penning, 2008, The international journal of biochemistry & cell biology.

Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab.

A. Luini, A. Goldhirsch, F. Bertolini, 2012, Breast.